Events2Join

Immunotherapy and Targeted Drugs for Eye Cancer


Immunotherapy and Targeted Drugs for Eye Cancer

Immunotherapy drugs work to stimulate the body's own immune system to help it recognize and attack cancer cells more effectively.

Chemotherapy for eye cancer | Cancer research UK

Or an immunotherapy drug called ipilimumab for uveal melanoma that has spread. Read more about targeted therapy. How you have chemotherapy. Chemotherapy eye ...

New Insights Could Unlock Immunotherapy for Rare, Deadly Eye ...

PITTSBURGH – New research from the University of Pittsburgh explains why metastatic uveal melanoma is resistant to conventional ...

Treating advanced eye cancer (ocular melanoma)

If uveal melanoma comes back in the liver, you can have different treatments. An immunotherapy drug called tebentafusp or Kimmtrack® may be used to control ...

What's New in Eye Cancer Research?

One of these drugs, tebentafusp, is now an option to treat some people with advanced eye melanomas. Other new immunotherapy drugs are now being ...

Immunotherapy for ocular melanoma: a bibliometric and ... - NCBI

Dacarbazine is a single FDA-approved anticancer drug that is now used as the chemotherapy drug of choice for the treatment of melanoma (57, 58).

What research is going on into eye cancer?

A type of immunotherapy are drugs called checkpoint inhibitors. Examples include ipilimumab, nivolumab and pembrolizumab. Trials have shown these drugs to be ...

New Drug Shows Promise for Treating Eye Cancer Called Uveal ...

Tebentafusp is the first systemic therapy proven to help people live longer with uveal melanoma. It's shattering the notion that “there's not ...

Tebentafusp Improves Survival in Advanced Uveal Melanoma - NCI

The drug, tebentafusp, is a type of treatment called a bispecific fusion protein. It works by helping immune cells get close enough to cancer ...

Clinical Trial Reports Promising New Immunotherapy for Advanced ...

A phase 2 clinical trial, focused on patients with previously treated metastatic uveal melanoma, studied the safety and efficacy of a newly approved ...

Metastatic Uveal Melanoma Treatment - WebMD

A new immunotherapy drug, tebentafusp (Kimmtrak), was approved by the FDA in January 2022. Tebentafusp is given by IV (through a vein) once a ...

Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review

Although the spectrum of their use continues to expand, ocular side effects are frequently encountered with the use of cancer therapeutics.

New immunotherapy approaches as the most effective treatment for ...

Immunotherapy can be very successful in treating uveal melanoma by bypassing tumor-induced immunosuppressive mechanisms.

Eye Cancer Treatment - MD Anderson Cancer Center

Surgery · Laser therapy · Radiation therapy · Cryoablation · Chemotherapy · Targeted therapy · Immunotherapy · Clinical trials.

How KEYTRUDA® (pembrolizumab) Works

KEYTRUDA is a type of immunotherapy that works by blocking the PD-1 pathway to help prevent cancer cells from hiding. KEYTRUDA helps the immune system do what ...

Ocular Melanoma (Eye Cancer) - Jefferson Health

Tebentafusp is the first and only FDA-approved immunotherapy treatment designed to treat advanced uveal melanoma in patients with certain gene mutations. The ...

Ocular (Eye) Melanoma - Symptoms and Causes - Penn Medicine

Targeted therapy, immunotherapy, radiation therapy and laser treatments destroy melanoma while preserving eye structure and vision, when possible. Meet your ...

Intraocular Melanoma Clinical Trials - NCI

Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

New Treatments Improving Prognosis for Stage 4 Melanoma Patients

Checkpoint Inhibitor Immunotherapy Drugs for Melanoma · Tumor-Infiltrating Lymphocyte (TIL) Therapy for Melanoma · New Drug Treatment for Uveal ...

OMF | Ocular Melanoma Foundation - Systemic Treatments

Several immunotherapies are FDA-approved for cutaneous melanoma and some are being studied in uveal melanoma. However, success with these treatments in OM has ...